Latest & greatest articles for measles

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on measles or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on measles and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for measles

1. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. (PubMed)

Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. The hypothesized link between the measles, mumps, rubella (MMR) vaccine and autism continues to cause concern and challenge vaccine uptake.To evaluate whether the MMR vaccine increases the risk for autism in children, subgroups of children, or time periods after vaccination.Nationwide cohort study.Denmark.657 461 children born in Denmark from 1999 through 31 December 2010, with follow-up from 1 year of age and through 31

Full Text available with Trip Pro

2019 Annals of Internal Medicine

2. Measles infection

Measles infection Measles infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Measles infection Last reviewed: February 2019 Last updated: March 2019 Summary Preventable by immunisation but high levels of coverage are required to prevent outbreaks of disease from occurring. No specific treatment for measles is available except for supportive care. Complications of measles are more common in immunocompromised (...) and poorly nourished individuals and include pneumonia, laryngotracheitis, otitis media, and encephalitis. Definition Measles is a highly infectious disease caused by measles virus, characterised by a maculopapular rash, cough, coryza, conjunctivitis, and a pathognomonic enanthem (Koplik's spots) with an incubation period of about 10 days. History and exam potential exposure to measles unimmunised or vaccine failure fever cough coryza conjunctivitis Koplik's spots maculopapular rash exposure to measles

2019 BMJ Best Practice

3. Dealing with a measles outbreak cost 20 times that of increasing vaccination cover

Dealing with a measles outbreak cost 20 times that of increasing vaccination cover Dealing with a measles outbreak cost 20 times that of increasing vaccination cover Discover Portal Discover Portal Dealing with a measles outbreak cost 20 times that of increasing vaccination cover Published on 7 June 2016 doi: New research show that the total cost of the 2012-13 measles outbreak in Merseyside (£4.4 million) was more than twenty times the cost of the vaccinations that could have prevented (...) it (£182,909). The cost incorporated for the first time estimates of lost employment from having measles or looking after someone with it, and accounted for 44% (£2 million) of the total. Other costs included treatment of patients and public health costs, such as tracing and vaccinating people in contact with measles cases. Measles vaccinations work, but need to reach 95% or more of a group to prevent measles outbreaks in the population. If the proportion of vaccinated people in an area falls below

2019 NIHR Dissemination Centre

4. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. (PubMed)

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. Chikungunya fever is an emerging viral disease and substantial threat to public health. We aimed to assess the safety, tolerability, and immunogenicity of a live-attenuated, measles-vectored chikungunya vaccine (MV-CHIK).In this double-blind, randomised, placebo-controlled and active-controlled phase 2 trial, we (...) enrolled healthy volunteers aged 18-55 years at four study sites in Austria and Germany. Participants were randomly assigned to receive intramuscular injections with MV-CHIK (5 × 104 or 5 × 105 50% tissue culture infectious dose), control vaccine, or measles prime and MV-CHIK, in two different administration regimens. Randomisation was done by use of three-digit randomisation codes in envelopes provided by a data management service. The participants and investigators were masked to treatment assignment

2018 Lancet

5. Measles

Measles Top results for measles - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading (...) history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for measles The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted

2018 Trip Latest and Greatest

6. Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants

Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants Rotavirus vaccines given to infants are safe and efficacious. A booster dose of rotavirus vaccine could extend protection into the second year of life in low-resource countries.We conducted an open-label, individual-randomized trial in Bamako, Mali. We assigned 600 infants aged 9-11 months to receive measles vaccine (MV), yellow fever

Full Text available with Trip Pro

2018 EvidenceUpdates

7. Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries (PubMed)

Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries Measles supplementary immunisation activities (SIAs) are an integral component of measles elimination in low-income and middle-income countries (LMICs). Despite their success in increasing vaccination coverage, there are concerns about their negative consequences on routine services. Few studies have conducted quantitative assessments of SIA (...) not appear to significantly impact utilisation of maternal and child services. We find a reduction in care-seeking for treatment of child cough (OR 0.67; 95% CI 0.48 to 0.95); and a few significant effects at the country level, suggesting the need for further investigation of the idiosyncratic effects of SIAs in each country.The paper contributes to the debate on vertical versus horizontal programmes to ensure universal access to vaccination. Measles SIAs do not seem to affect care-seeking for critical

Full Text available with Trip Pro

2018 BMJ global health

8. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study (PubMed)

Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study Beyond their impact on health, vaccines can lead to large economic benefits. While most economic evaluations of vaccines have focused on the health impact of vaccines at a national scale, it is critical to understand how their impact is distributed along population subgroups.We build a financial risk protection model (...) to evaluate the impact of immunisation against measles, severe pneumococcal disease and severe rotavirus for birth cohorts vaccinated over 2016-2030 for three scenarios in 41 Gavi-eligible countries: no immunisation, current immunisation coverage forecasts and the current immunisation coverage enhanced with funding support. We distribute modelled disease cases per socioeconomic group and derive the number of cases of: (1) catastrophic health costs (CHCs) and (2) medical impoverishment.In the absence

Full Text available with Trip Pro

2018 BMJ global health

9. Dealing with a measles outbreak cost 20 times that of increasing vaccination cover

Dealing with a measles outbreak cost 20 times that of increasing vaccination cover Dealing with a measles outbreak cost 20 times that of increasing vaccination cover Discover Portal Discover Portal Dealing with a measles outbreak cost 20 times that of increasing vaccination cover Published on 7 June 2016 doi: New research show that the total cost of the 2012-13 measles outbreak in Merseyside (£4.4 million) was more than twenty times the cost of the vaccinations that could have prevented (...) it (£182,909). The cost incorporated for the first time estimates of lost employment from having measles or looking after someone with it, and accounted for 44% (£2 million) of the total. Other costs included treatment of patients and public health costs, such as tracing and vaccinating people in contact with measles cases. Measles vaccinations work, but need to reach 95% or more of a group to prevent measles outbreaks in the population. If the proportion of vaccinated people in an area falls below

2018 NIHR Dissemination Centre

10. Measles infection

Measles infection Measles infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Measles infection Last reviewed: February 2019 Last updated: March 2019 Summary Preventable by immunisation but high levels of coverage are required to prevent outbreaks of disease from occurring. No specific treatment for measles is available except for supportive care. Complications of measles are more common in immunocompromised (...) and poorly nourished individuals and include pneumonia, laryngotracheitis, otitis media, and encephalitis. Definition Measles is a highly infectious disease caused by measles virus, characterised by a maculopapular rash, cough, coryza, conjunctivitis, and a pathognomonic enanthem (Koplik's spots) with an incubation period of about 10 days. History and exam potential exposure to measles unimmunised or vaccine failure fever cough coryza conjunctivitis Koplik's spots maculopapular rash exposure to measles

2018 BMJ Best Practice

11. Progress towards regional measles elimination – worldwide, 2000–2016 – Progrès accomplis dans le monde en vue de l’élimination régionale de la rougeole, 2000-2016

Progress towards regional measles elimination – worldwide, 2000–2016 – Progrès accomplis dans le monde en vue de l’élimination régionale de la rougeole, 2000-2016 Progress towards regional measles elimination – worldwide, 2000–2016 – Progrès accomplis dans le monde en vue de l’élimination régionale de la rougeole, 2000-2016 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links (...) Progress towards regional measles elimination – worldwide, 2000–2016 – Progrès accomplis dans le monde en vue de l’élimination régionale de la rougeole, 2000-2016 View/ Open View Statistics Altmetrics Share Citation World Health Organization = Organisation mondiale de la Santé . (‎2017)‎. Progress towards regional measles elimination – worldwide, 2000–2016 – Progrès accomplis dans le monde en vue de l’élimination régionale de la rougeole, 2000-2016. Weekly Epidemiological Record = Relevé

2017 WHO

12. Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent (PubMed)

Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent Hematopoietic stem cell (HSC)-based gene therapy trials are now moving toward the use of lentiviral vectors (LVs) with success. However, one challenge in the field remains: efficient transduction of HSCs without compromising their stem cell potential. Here we showed that measles virus glycoprotein-displaying LVs (hemagglutinin and fusion protein LVs [H/F-LVs]) were capable

Full Text available with Trip Pro

2017 Blood advances

13. Incidence of Measles in the United States, 2001–2015 (PubMed)

Incidence of Measles in the United States, 2001–2015 28973240 2017 10 23 2018 11 13 1538-3598 318 13 2017 10 03 JAMA JAMA Incidence of Measles in the United States, 2001-2015. 1279-1281 10.1001/jama.2017.9984 Clemmons Nakia S NS Division of Viral Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia. Wallace Gregory S GS Division of Viral Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia. Patel Manisha M Division of Viral Diseases, US Centers (...) for Disease Control and Prevention, Atlanta, Georgia. Gastañaduy Paul A PA Division of Viral Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia. eng CC999999 Intramural CDC HHS United States Journal Article United States JAMA 7501160 0098-7484 0 Measles Vaccine AIM IM Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Disease Outbreaks statistics & numerical data Humans Incidence Infant Measles epidemiology Measles Vaccine Middle Aged United States epidemiology Young

Full Text available with Trip Pro

2017 JAMA

14. Chickenpox and measles clusters among college students in Pune, Maharashtra (PubMed)

Chickenpox and measles clusters among college students in Pune, Maharashtra Chickenpox and measles, both vaccine preventable febrile rash illnesses, present in a comparatively severe form among young adults/adults than among children. Immunity levels against chickenpox are not known in India and those against measles have been found variable across the country. Places where students or adults/young adults from various parts of the country come together pose a peculiar challenge in preventive (...) policy making regarding these diseases. In this article, we present findings from parallel outbreaks of the two diseases in a graduate/postgraduate institute in the city of Pune. A team from National Institute of Virology [Pune] investigated outbreak of febrile rash illness in a premier graduate institute and found that it was a case of two parallel outbreaks of chickenpox and measles. In this outbreak chickenpox cases did not present with greater severity but measles cases were severe. The concerned

Full Text available with Trip Pro

2017 Virusdisease

15. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands. (PubMed)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands. Objectives To investigate whether measles, mumps, and rubella (MMR) vaccine has positive non-specific effects in a high income setting and to compare rates of hospital admissions for infections between children aged ≤2 years who received live MMR vaccine and those who received an inactivated vaccine against diphtheria, tetanus, pertussis, polio

Full Text available with Trip Pro

2017 BMJ

16. A killer nailed: a reconstruction of Maldives triumph over measles.

A killer nailed: a reconstruction of Maldives triumph over measles. A killer nailed: a reconstruction of Maldives triumph over measles. JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links A killer nailed: a reconstruction of Maldives triumph over measles. View/ Open View Statistics Altmetrics Share Citation World Health Organization. Regional Office for South-East Asia . (‎2017 (...) )‎. A killer nailed: a reconstruction of Maldives triumph over measles.. World Health Organization. Regional Office for South-East Asia. ISBN 9789290225942 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ 2015 )‎  Bennett, John V. ; Fernandez de Castro, Jorge ; Valdespino-Gomez, Jose Luis ; Garcia-Garcia, Ma de Lourdes ; Islas-Romero, Rocio ; Echaniz-Aviles, Gabriela ; Jimenez-Corona, Aida ; Sepulveda-Amor, Jaime (‎ 2002

2017 WHO

17. Banished from Bhutan: the story of how a small mountain kingdom eliminated measles

Banished from Bhutan: the story of how a small mountain kingdom eliminated measles Banished from Bhutan: the story of how a small mountain kingdom eliminated measles JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Banished from Bhutan: the story of how a small mountain kingdom eliminated measles View/ Open View Statistics Altmetrics Share Citation World Health Organization (...) . Regional Office for South-East Asia . (‎2017)‎. Banished from Bhutan: the story of how a small mountain kingdom eliminated measles. World Health Organization. Regional Office for South-East Asia. ISBN 9789290225935 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization. Regional Office for South-East Asia (‎ SEA-Immun-109 , 2017 )‎ In order to achieve the goal of measles elimination and rubella control by 2020, case-based measles

2017 WHO

18. Progress towards measles elimination in Bangladesh, 2000–2016– Progrès réalisés en vue d’éliminer la rougeole au Bangladesh, 2000-2016

Progress towards measles elimination in Bangladesh, 2000–2016– Progrès réalisés en vue d’éliminer la rougeole au Bangladesh, 2000-2016 Progress towards measles elimination in Bangladesh, 2000–2016– Progrès réalisés en vue d’éliminer la rougeole au Bangladesh, 2000-2016 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Progress towards measles elimination in Bangladesh, 2000–2016 (...) – Progrès réalisés en vue d’éliminer la rougeole au Bangladesh, 2000-2016 View/ Open View Statistics Altmetrics Share Citation World Health Organization = Organisation mondiale de la Santé . (‎2017)‎. Progress towards measles elimination in Bangladesh, 2000–2016– Progrès réalisés en vue d’éliminer la rougeole au Bangladesh, 2000-2016. Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire, 92 (‎29/30)‎, 405 - 412. World Health Organization = Organisation mondiale de la Santé. Journal Weekly

2017 WHO

19. Measles. (PubMed)

Measles. Measles is a highly contagious disease that results from infection with measles virus and is still responsible for more than 100 000 deaths every year, down from more than 2 million deaths annually before the introduction and widespread use of measles vaccine. Measles virus is transmitted by the respiratory route and illness begins with fever, cough, coryza, and conjunctivitis followed by a characteristic rash. Complications of measles affect most organ systems, with pneumonia (...) accounting for most measles-associated morbidity and mortality. The management of patients with measles includes provision of vitamin A. Measles is best prevented through vaccination, and the major reductions in measles incidence and mortality have renewed interest in regional elimination and global eradication. However, urgent efforts are needed to increase stagnating global coverage with two doses of measles vaccine through advocacy, education, and the strengthening of routine immunisation systems. Use

2017 Lancet

20. Zinc supplementation for the treatment of measles in children. (PubMed)

Zinc supplementation for the treatment of measles in children. Measles is an important cause of childhood morbidity and mortality globally, despite increasing vaccine coverage. Zinc plays a significant role in the maintenance of normal immunological functions, therefore supplements given to zinc-deficient children will increase the availability of zinc and could reduce measles-related morbidity and mortality. This is an update of a review first published in 2015.To assess the effects of zinc (...) with 95% confidence intervals (CI). We included only one study, and did not conduct meta-analysis.We did not identify any new studies for inclusion in this update. One RCT met our inclusion criteria. The study was conducted in India and included 85 children diagnosed with measles and pneumonia. The trial showed no significant difference in mortality between children with measles and pneumonia who received zinc supplements and those who received placebo (RR 0.34, 95% CI 0.01 to 8.14

Full Text available with Trip Pro

2017 Cochrane